Ligand validation:6XQP

2LJ: 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol

2LJ is a Ligand Of Interest in 6XQP designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XQP_2LJ_A_301	58%	37%	0.18	0.961	1.66	0.82	1	-	1	0	100%	0.567
6XQP_2LJ_C_301	52%	56%	0.198	0.956	1.25	0.48	2	-	2	1	100%	0.615
6PUF_2LJ_A_301	89%	46%	0.093	0.973	1.36	0.74	2	-	1	0	100%	0.9545
4PJB_2LJ_C_301	87%	20%	0.109	0.981	1.85	1.53	2	3	0	0	100%	1
5D5M_2LJ_A_600	84%	68%	0.118	0.981	0.46	0.76	-	1	1	0	100%	1
5D7J_2LJ_E_600	80%	51%	0.118	0.966	0.68	1.19	1	3	0	0	100%	1
4PJA_2LJ_A_301	77%	36%	0.14	0.981	1.45	1.08	3	2	1	0	100%	1
4PJ9_2LJ_A_301	76%	42%	0.148	0.986	1.2	1.05	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.